June 14, 2024 07:00 AM EDTUpdated 09:00 AM

Bill Haney gives up CEO post at Skyhawk, becomes chairman; Bayer parts ways with head of biotech

Alex Hoffman

Copy Chief

Kathy Wong

Editor

→ Bill Haney has helped Skyhawk Therapeutics stand out in the wave of biotechs looking to drug RNA, taking over from fellow co-founder Kathleen McCarthy …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Bill Haney gives up CEO post at Skyhawk, becomes chairman; Bayer parts ways with head of biotech

Alex Hoffman

Copy Chief

Kathy Wong

Editor

Sign up to read this article for free.

The Endpoints 2024 winners and losers list: Who was up and who was down in biopharma

Exclusive: Florida cancer biotech raises $100M Series A

CMS explains what went into its first round of drug price negotiations

CagriSema’s weight loss data disappointed. What does Novo do next?

FDA approves Lilly's Zepbound for sleep apnea, likely cracking open Medicare market

Three drugmakers sue US over 340B discounts to STD clinics they allege don’t qualify

Bill Haney gives up CEO post at Sky­hawk, be­comes chair­man; Bay­er parts ways with head of biotech

Copy Chief

Editor

Sign up to read this article for free.

more like this

Bill Haney gives up CEO post at Skyhawk, becomes chairman; Bayer parts ways with head of biotech